UNIGENE LABORATORIES INC Revenue
UNIGENE LABORATORIES INC reported Revenue of $613.77 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2013-05-14
- UNIGENE LABORATORIES INC revenues for the quarter ending 2013-03-31 was $613.77K, a 64.95% decline year-over-year.
- UNIGENE LABORATORIES INC revenues for the quarter ending 2012-12-31 was $1.54M, a 87.69% decline year-over-year.
- UNIGENE LABORATORIES INC revenues for the quarter ending 2012-09-30 was $3.41M, a 0.47% decline year-over-year.
- UNIGENE LABORATORIES INC revenues for the quarter ending 2012-06-30 was $2.74M, a 10.87% increase year-over-year.
- UNIGENE LABORATORIES INC revenues for fiscal 2012 was $9.44M, a 53.98% decline from fiscal 2011.
- UNIGENE LABORATORIES INC revenues for fiscal 2011 was $20.51M, a 80.85% increase from fiscal 2010.
- UNIGENE LABORATORIES INC revenues for fiscal 2010 was $11.34M, a 11.35% decline from fiscal 2009.
- UNIGENE LABORATORIES INC revenues for fiscal 2009 was $12.79M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2013-03-31 | $613.77K 10-Q · filed 2013-05-14 | $2.15M derived: sum of 2 quarters · filed 2013-05-14 | $5.56M derived: sum of 3 quarters · filed 2013-05-14 | $8.30M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $4.95M derived: sum of 2 quarters · filed 2013-03-15 | $7.69M derived: sum of 3 quarters · filed 2013-03-15 | $9.44M 10-K · filed 2013-03-15 |
| 2012-09-30 | $3.41M 10-Q · filed 2013-01-31 | $6.15M derived: sum of 2 quarters · filed 2013-01-31 | $7.90M 10-Q · filed 2013-01-31 | $20.39M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-06-30 | $2.74M 10-Q/A · filed 2013-01-31 | $4.49M 10-Q/A · filed 2013-01-31 | $16.97M derived: sum of 3 quarters · filed 2013-05-14 | $20.40M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-03-31 | $1.75M 10-Q · filed 2013-05-14 | $14.24M derived: sum of 2 quarters · filed 2013-05-14 | $17.66M derived: sum of 3 quarters · filed 2013-05-14 | $20.13M derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | $12.48M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $15.91M derived: sum of 2 quarters · filed 2013-03-15 | $18.38M derived: sum of 3 quarters · filed 2013-03-15 | $20.51M 10-K · filed 2013-03-15 |
| 2011-09-30 | $3.43M 10-Q · filed 2013-01-31 | $5.90M derived: sum of 2 quarters · filed 2013-01-31 | $8.02M 10-Q · filed 2013-01-31 | $10.95M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $2.47M 10-Q/A · filed 2013-01-31 | $4.59M 10-Q/A · filed 2013-01-31 | $7.52M derived: sum of 3 quarters · filed 2013-03-15 | $10.37M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $2.13M 10-Q/A · filed 2013-01-31 | $5.05M derived: sum of 2 quarters · filed 2013-03-15 | $7.91M derived: sum of 3 quarters · filed 2013-03-15 | $10.93M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $5.78M derived: sum of 2 quarters · filed 2013-03-15 | $8.81M derived: sum of 3 quarters · filed 2013-03-15 | $11.34M 10-K · filed 2013-03-15 |
| 2010-09-30 | $2.86M 10-Q · filed 2011-11-09 | $5.88M derived: sum of 2 quarters · filed 2011-11-09 | $8.42M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $3.03M 10-Q · filed 2011-08-09 | $5.56M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $12.79M 10-K/A · filed 2013-01-31 |